MEI Pharma Inc (MEIP)
3.06
-0.01
(-0.33%)
USD |
NASDAQ |
Nov 04, 16:00
3.06
0.00 (0.00%)
After-Hours: 20:00
MEI Pharma Enterprise Value: -17.89M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | -17.89M |
| October 31, 2024 | -17.69M |
| October 30, 2024 | -17.62M |
| October 29, 2024 | -17.22M |
| October 28, 2024 | -17.79M |
| October 25, 2024 | -20.16M |
| October 24, 2024 | -20.12M |
| October 23, 2024 | -20.09M |
| October 22, 2024 | -20.02M |
| October 21, 2024 | -20.09M |
| October 18, 2024 | -19.89M |
| October 17, 2024 | -20.02M |
| October 16, 2024 | -19.89M |
| October 15, 2024 | -20.29M |
| October 14, 2024 | -20.56M |
| October 11, 2024 | -20.36M |
| October 10, 2024 | -20.36M |
| October 09, 2024 | -20.49M |
| October 08, 2024 | -20.29M |
| October 07, 2024 | -19.89M |
| October 04, 2024 | -19.62M |
| October 03, 2024 | -20.02M |
| October 02, 2024 | -20.02M |
| October 01, 2024 | -19.69M |
| September 30, 2024 | -19.36M |
| Date | Value |
|---|---|
| September 27, 2024 | -19.02M |
| September 26, 2024 | -19.02M |
| September 25, 2024 | -19.29M |
| September 24, 2024 | -18.69M |
| September 23, 2024 | -18.82M |
| September 20, 2024 | -18.49M |
| September 19, 2024 | -17.42M |
| September 18, 2024 | -18.09M |
| September 17, 2024 | -18.36M |
| September 16, 2024 | -18.02M |
| September 13, 2024 | -18.16M |
| September 12, 2024 | -17.96M |
| September 11, 2024 | -18.22M |
| September 10, 2024 | -17.72M |
| September 09, 2024 | -18.69M |
| September 06, 2024 | -17.69M |
| September 05, 2024 | -17.36M |
| September 04, 2024 | -17.69M |
| September 03, 2024 | -17.49M |
| August 30, 2024 | -17.69M |
| August 29, 2024 | -16.62M |
| August 28, 2024 | -17.62M |
| August 27, 2024 | -17.16M |
| August 26, 2024 | -17.16M |
| August 23, 2024 | -17.42M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-114.34M
Minimum
Mar 28 2022
362.99M
Maximum
Jun 23 2020
45.32M
Average
-17.62M
Median
Aug 20 2024
Enterprise Value Benchmarks
| Avid Bioservices Inc | 775.66M |
| NovaBay Pharmaceuticals Inc | 3.615M |
| Palatin Technologies Inc | 13.93M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.69M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.41M |
| Total Expenses (Quarterly) | 8.081M |
| EPS Diluted (Quarterly) | -2.76 |
| Earnings Yield | 87.25% |
| Operating Earnings Yield | 180.2% |
| Normalized Earnings Yield | 199.75 |